PYC Therapeutics Ltd (PYC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.203x

Based on the latest financial reports, PYC Therapeutics Ltd (PYC) has a cash flow conversion efficiency ratio of -0.203x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-34.54 Million ≈ $-24.44 Million USD) by net assets (AU$170.01 Million ≈ $120.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check PYC strategic asset allocation to assess the company's strategic physical and investment asset allocation.

PYC Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how PYC Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See PYC Therapeutics Ltd (PYC) shareholders funds for net asset value and shareholders' equity analysis.

PYC Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PYC Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Civista Bancshares Inc NASDAQ:CIVB	0.021x
Peapack-Gladstone Financial NASDAQ:PGC	0.055x
Northpointe Bancshares, Inc. NYSE:NPB	0.159x
Wuhan Langold Real Estate Co Ltd SHE:002305	-0.748x
Haier Smart Home Co Ltd XETRA:690D	0.049x
Cass Information Systems Inc NASDAQ:CASS	0.060x
Edom Technology Co Ltd TW:3048	-0.709x
Caribbean Utilities Company Ltd TO:CUP-U	0.054x

Annual Cash Flow Conversion Efficiency for PYC Therapeutics Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of PYC Therapeutics Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see PYC Therapeutics Ltd (PYC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$170.01 Million ≈ $120.29 Million	AU$-51.56 Million ≈ $-36.48 Million	-0.303x	+36.30%
2024-06-30	AU$81.05 Million ≈ $57.35 Million	AU$-38.59 Million ≈ $-27.30 Million	-0.476x	+44.55%
2023-06-30	AU$28.44 Million ≈ $20.12 Million	AU$-24.42 Million ≈ $-17.28 Million	-0.859x	-58.47%
2022-06-30	AU$40.20 Million ≈ $28.45 Million	AU$-21.78 Million ≈ $-15.41 Million	-0.542x	-147.78%
2021-06-30	AU$53.92 Million ≈ $38.15 Million	AU$-11.79 Million ≈ $-8.34 Million	-0.219x	-14.86%
2020-06-30	AU$30.20 Million ≈ $21.37 Million	AU$-5.75 Million ≈ $-4.07 Million	-0.190x	+76.60%
2019-06-30	AU$6.30 Million ≈ $4.46 Million	AU$-5.13 Million ≈ $-3.63 Million	-0.814x	+80.02%
2018-06-30	AU$1.65 Million ≈ $1.17 Million	AU$-6.71 Million ≈ $-4.75 Million	-4.072x	-1815.51%
2017-06-30	AU$8.86 Million ≈ $6.27 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.213x	+60.86%
2016-06-30	AU$5.83 Million ≈ $4.13 Million	AU$-3.17 Million ≈ $-2.24 Million	-0.543x	+78.94%
2015-06-30	AU$962.03K ≈ $680.70K	AU$-2.48 Million ≈ $-1.76 Million	-2.579x	-199.69%
2014-06-30	AU$3.72 Million ≈ $2.63 Million	AU$-3.20 Million ≈ $-2.26 Million	-0.861x	+55.58%
2013-06-30	AU$1.19 Million ≈ $845.45K	AU$-2.32 Million ≈ $-1.64 Million	-1.938x	-25.63%
2012-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.15 Million ≈ $-2.94 Million	-1.542x	-128.13%
2011-06-30	AU$4.35 Million ≈ $3.08 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.676x	-108.14%
2010-06-30	AU$-437.08K ≈ $-309.26K	AU$-3.63 Million ≈ $-2.57 Million	8.302x	+509.05%
2009-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-3.88 Million ≈ $-2.74 Million	-2.030x	-9.99%
2008-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.97 Million ≈ $-3.52 Million	-1.845x	-31.11%
2007-06-30	AU$2.20 Million ≈ $1.55 Million	AU$-3.09 Million ≈ $-2.19 Million	-1.407x	-5.96%
2006-06-30	AU$2.11 Million ≈ $1.50 Million	AU$-2.81 Million ≈ $-1.99 Million	-1.328x	-476.72%
2005-06-30	AU$5.78 Million ≈ $4.09 Million	AU$-1.33 Million ≈ $-942.05K	-0.230x	-549.11%
2004-06-30	AU$546.00K ≈ $386.33K	AU$28.00K ≈ $19.81K	0.051x	--

About PYC Therapeutics Ltd

AU:PYC Australia Biotechnology

Market Cap

$595.86 Million

AU$842.13 Million AUD

Market Cap Rank

#11644 Global

#296 in Australia

Share Price

AU$1.41

Change (1 day)

+2.17%

52-Week Range

AU$0.85 - AU$1.74

All Time High

AU$2.05